YTHDC2 Promotes Malignant Phenotypes of Breast Cancer Cells

Figure 1

Representative immunostaining tissues with anti-YTHDC2 monoclonal antibody. Formalin-fixed paraffin-embedded tissues derived from breast cancer patients were stained with anti-YTHDC2 monoclonal antibody. Representative cases are shown in (a)–(d). (a)–(d) are determined YTHDC2-negative, 1+, 2+, and 3+ staining intensity, respectively.

(a)

(b)

(c)

(d)